======= MRGBP ======= == Gene Information == * **Official Symbol**: MRGBP * **Official Name**: MRG domain binding protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55257|55257]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NV56|Q9NV56]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MRGBP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MRGBP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611157|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. |CT20| |NuA4 histone acetyltransferase complex| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |regulation of growth| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-2.31| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-1.98| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|-1.96| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.92| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-1.85| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.82| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.564| Global Fraction of Cell Lines Where Essential: 275/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|12/28| |blood|10/28| |bone|10/25| |breast|18/33| |central nervous system|22/56| |cervix|1/4| |colorectal|7/17| |esophagus|1/13| |fibroblast|1/1| |gastric|5/15| |kidney|9/21| |liver|6/20| |lung|21/75| |lymphocyte|7/14| |ovary|9/26| |pancreas|8/24| |peripheral nervous system|6/16| |plasma cell|10/15| |prostate|1/1| |skin|11/24| |soft tissue|5/7| |thyroid|1/2| |upper aerodigestive|7/22| |urinary tract|7/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 586 * **Expression level (log2 read counts)**: 5.09 {{:chemogenomics:nalm6 dist.png?nolink |}}